UN's health body urges Hepatitis C offensive

April 13, 2018
Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.

Hepatitis C is easily cured. Yet, about 400,000 people die of the liver disease every year as only a smattering get the medicine they need.

On Friday, the World Health Organization (WHO) urged governments to attack the problem with more urgency, and more money.

Only about three million people from an estimated 71 million Hepatitis C virus (HCV) carriers, received the treatment they needed, the UN's health organ said at an International Liver Congress in Paris.

"We very much encourage leaders in countries and politicians, policymakers, to... include Hepatitis C treatment into their broader health portfolio and really also find the domestic resources that are needed to take this forward," said Gottfried Hirnschall, head of the WHO's global hepatitis programme.

The price of a cure ranges from about $200 (162 euros) to several thousand dollars per person—excluding diagnostic tests and healthcare salaries and infrastructure.

But "by really frontloading and treating people, and treating them as quickly as possible... you save costs later," Hirnschall told AFP.

"You save costs that you have if somebody progresses to or other diseases that require hospitalisation, in some instances very costly liver transplants, (or) tertiary care."

There is no vaccine for Hepatitis C, and curing it is the best way to prevent virus spread.

HCV is most commonly passed on through infected blood—either by soiled needles used to inject legal or illegal drugs, or blood transfusions.

Only about one in five people even know they are infected. Many go on to develop cancer or cirrhosis of the liver.

'Incredible opportunity'

A new category of drug called direct-acting antivirals (DAAs), described by Hirnschall as "revolutionary", can cure all six major HCV strains, with a success rate of more than 90 percent.

It comes as a once-daily pill taken for eight to 12 weeks.

If all infected people could get it, the treatment would slash liver cancer deaths by 80 percent, says the WHO.

Some countries, such as Egypt, Pakistan, China, and Brazil, have "really started to increase access" to HCV medicines, said Hirnschall—some relying on special licencing agreements that allows for the production of cheaper, generic versions .

As a result, the majority of live in low- to middle-income countries where prices today are but a fraction of the $84,000 initially charged in the United States for a three-month course.

In many rich countries, prices remain high, said Hirnschall.

The WHO is reviewing its guidelines on HCV treatment, he added, and will propose that every person older than 12 must have access to DAA.

Governments right now have "an incredible opportunity," said Hirnschall, "with medicines becoming available that are simple, that are cheap, that can now be delivered not only through specialist hepatologists but also through the primary care system.

"There's no reason to not scale this up, to not take this forward."

The WHO will release an estimate of the global price tag in June.

Two years ago, health ministers agreed to eliminate viral as a by 2030—meaning to reduce new infections by 90 percent and deaths by 65 percent.

On Thursday, the conference heard that only six European countries—the Netherlands, Iceland, Georgia, France, Spain, Switzerland— were on track to meet the goal.

Research published last year showed the number of Hepatitis C infections in the United States had nearly tripled in five years, partly due to a rise in needle-sharing fuelled by the opioid epidemic.

Explore further: WHO urges stepped-up battle against hepatitis B

Related Stories

WHO urges stepped-up battle against hepatitis B

March 12, 2015
The world can beat the liver-attacking hepatitis B virus, which results in some 650.000 deaths a year, the World Health Organization said Thursday, releasing its first treatment guidelines for the disease.

Deaths from liver cancer nearly double since the 1990s, new figures reveal

February 1, 2018
Over the last two decades, deaths caused by liver cancer have increased by 80%, making it one of the fastest-growing causes of cancer deaths worldwide.

Experts demand better prevention, treatment for children with hepatitis

November 3, 2017
Experts at the second World Hepatitis Summit Friday called for improved preventative measures and treatment for 52 million children suffering from the disease, on the final day of the three-day event in Sao Paulo.

Can England really eliminate hepatitis C by 2025?

February 5, 2018
The World Health Organisation set a goal to eliminate hepatitis C by 2030. The NHS recently announced that it will go one better than that: it will eliminate the disease in England by 2025. In theory, the goal is achievable, ...

Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

Only nine countries on track to eliminate hepatitis C

November 1, 2017
New data on hepatitis C released by the Polaris Observatory, and presented today at the World Hepatitis Summit (WHS) in Sao Paulo, Brazil shows that nine countries—Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.